Added to YB: 2025-11-21
Pitch date: 2025-10-16
DXCM [bullish]
DexCom, Inc.
-0.8%
current return
Author Info
No bio for this author
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Market Cap
$23.5B
Pitch Price
$66.26
Price Target
N/A
Dividend
N/A
EV/EBITDA
21.49
P/E
33.52
EV/Sales
5.04
Sector
Health Care Equipment and Supplies
Category
growth
Aristotle Atlantic Core Equity Strategy New Position: DexCom, Inc.
DXCM (new position): CGM leader w/ clean balance sheet & robust FCF generation. Organic revenue growth in FY25, multi-year earnings expansion ahead. Stelo launch targeting non-diabetics, G7 transition w/ longer sensor life. Expanding into large non-intensive type 2 diabetes market w/ positive reimbursement trends.
Read full article (1 min)